Laman UtamaORX • STO
add
Orexo AB
Tutup sebelumnya
kr 20.75
Julat hari
kr 20.85 - kr 21.00
Julat tahun
kr 12.50 - kr 43.40
Permodalan pasaran
737.67J SEK
Bilangan Purata
50.32K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
STO
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (SEK) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 3.30J | -97.94% |
Perbelanjaan pengendalian | 80.70J | — |
Pendapatan bersih | 724.80J | — |
Margin untung bersih | 21.96K | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -46.80J | — |
Kadar cukai berkesan | -0.09% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (SEK) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 912.40J | 639.98% |
Jumlah aset | 1.30B | 119.03% |
Jumlah liabiliti | 812.20J | 12.63% |
Jumlah ekuiti | 490.60J | — |
Syer tertunggak | 34.71J | — |
Harga kepada buku | 1.47 | — |
Pulangan pada aset | -21.96% | — |
Pulangan pada modal | -32.02% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (SEK) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 724.80J | — |
Tunai daripada operasi | 806.20J | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | 4.80J | — |
Perubahan bersih dalam tunai | 806.70J | — |
Aliran tunai bebas | 40.78J | — |
Perihal
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Diasaskan
1995
Tapak web
Pekerja
74
